US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
US4477464A
(en)
|
1983-02-10 |
1984-10-16 |
Ciba-Geigy Corporation |
Hetero-benzazepine derivatives and their pharmaceutical use
|
EP0187037A3
(en)
|
1984-12-21 |
1988-03-23 |
Takeda Chemical Industries, Ltd. |
Piperidine derivatives, their production and use
|
EP0322779A3
(en)
|
1987-12-29 |
1991-05-08 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Benzolactam compounds and pharmaceutical uses thereof
|
JPH0334977A
(ja)
|
1989-06-29 |
1991-02-14 |
Yoshitomi Pharmaceut Ind Ltd |
イミダゾリルベンゾラクタム化合物
|
IL98526A0
(en)
|
1990-06-18 |
1992-07-15 |
Merck & Co Inc |
Pyridones,processes for their preparation and pharmaceutical compositions containing them
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
US5206234A
(en)
|
1990-10-22 |
1993-04-27 |
Merck & Co., Inc. |
Benzolactam analogs as antagonists of cck
|
US5206235A
(en)
|
1991-03-20 |
1993-04-27 |
Merck & Co., Inc. |
Benzo-fused lactams that promote the release of growth hormone
|
US5457196A
(en)
|
1991-09-27 |
1995-10-10 |
Merrell Dow Pharmaceuticals Inc. |
2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
DE69220744T2
(de)
|
1991-09-27 |
1997-11-13 |
Merrell Pharma Inc |
2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
|
JP3358069B2
(ja)
|
1991-12-24 |
2002-12-16 |
武田薬品工業株式会社 |
三環性複素環類、その製造法及び剤
|
US5484917A
(en)
|
1993-06-16 |
1996-01-16 |
Pfizer Inc. |
Substituted tetrahydrobenzazepinones
|
US5618808A
(en)
|
1992-07-01 |
1997-04-08 |
Pfizer, Inc. |
Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
|
US5420271A
(en)
|
1992-08-24 |
1995-05-30 |
Merrell Dow Pharmaceuticals, Inc. |
2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
|
DK0656001T3
(da)
|
1992-08-24 |
2000-04-03 |
Merrell Pharma Inc |
Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere
|
US5283241A
(en)
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
SK65094A3
(en)
|
1992-09-03 |
1995-03-08 |
Boehringer Ingelheim Kg |
Aminoacid derivatives, process for producing the same and pharmaceutical compositions containing these derivatives
|
US5583130A
(en)
|
1992-09-25 |
1996-12-10 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5317017A
(en)
|
1992-09-30 |
1994-05-31 |
Merck & Co., Inc. |
N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
|
US5374721A
(en)
|
1992-10-14 |
1994-12-20 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
DE69332946T2
(de)
|
1992-10-16 |
2004-05-19 |
Suprex Corp. |
Automatisierte extrakion mittels eines superkritischen fluidum
|
GB2272439A
(en)
|
1992-11-13 |
1994-05-18 |
Merck & Co Inc |
Benzo-fused lactams that inhibit the release of growth hormone
|
US5284841A
(en)
|
1993-02-04 |
1994-02-08 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
GB9307833D0
(en)
|
1993-04-15 |
1993-06-02 |
Glaxo Inc |
Modulators of cholecystokinin and gastrin
|
EP0703222A1
(en)
|
1993-05-13 |
1996-03-27 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3-aminoazepine compound and pharmaceutical use thereof
|
US5430144A
(en)
|
1993-07-26 |
1995-07-04 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
US5606054A
(en)
|
1993-12-14 |
1997-02-25 |
Merck & Co., Inc. |
Heterocyclic-fused lactams promote release of growth hormone
|
KR970702274A
(ko)
|
1994-04-14 |
1997-05-13 |
앨런 헤스케쓰 |
콜레시스토키닌 또는 가스트린을 조절하는 5-헤테로시클릭-1, 5-벤조디아제핀(CCK or Gastrin Modulating 5-Heterocyclic-1,5-Benzodiazepines)
|
EE9600186A
(et)
|
1994-05-07 |
1997-08-15 |
Boehringer Ingelheim Kg |
Neurokiniini (tahhüülkiniini) antagonistid
|
IL114955A
(en)
|
1994-08-17 |
1999-12-22 |
Novo Nordisk As |
N-substituted naphthofused lactams and pharmaceutical compositions containing them
|
GB9420763D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
Acetamide derivatives
|
GB9420748D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
1,5 benzodiazepine derivatives
|
GB9420747D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
1,5 benzodiazepine derivatives
|
CA2205463A1
(en)
|
1994-11-17 |
1996-05-30 |
Ciba Specialty Chemicals Holding Inc. |
Monomers and composition which can be crosslinked and crosslinked polymers
|
US5587375A
(en)
|
1995-02-17 |
1996-12-24 |
Bristol-Myers Squibb Company |
Azepinone compounds useful in the inhibition of ACE and NEP
|
US5726171A
(en)
|
1995-06-07 |
1998-03-10 |
Merck & Co Inc |
N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
|
US5691331A
(en)
|
1995-06-07 |
1997-11-25 |
Merck & Co., Inc. |
N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
|
US5700797A
(en)
|
1995-06-07 |
1997-12-23 |
Merck & Co, Inc. |
N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
|
JPH11506760A
(ja)
|
1995-06-07 |
1999-06-15 |
メルク エンド カンパニー インコーポレーテッド |
新規なn−(2,4−ジオキソ−2,3,4,5−テトラヒドロ−1h−1,5−ベンゾジアゼピン−3イル)−3−アミド
|
EP0761680A3
(en)
|
1995-09-12 |
1999-05-06 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
|
CZ288149B6
(en)
|
1995-09-15 |
2001-05-16 |
Sanofi Synthelabo |
Derivatives of 2(1H)-quinolone, process of their preparation and pharmaceutical preparation in which they are comprised
|
EP0900791A1
(en)
|
1995-12-27 |
1999-03-10 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole derivatives and drugs containing the same as the active ingredient
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
JPH09295996A
(ja)
|
1996-03-06 |
1997-11-18 |
Takeda Chem Ind Ltd |
システインプロテアーゼ阻害化合物
|
PL325341A1
(en)
|
1996-06-29 |
1998-07-20 |
Samjin Pharmaceutical Co |
Derivatives od piperazine and method of obtaining them
|
DE19638020A1
(de)
|
1996-09-18 |
1998-03-19 |
Solvay Pharm Gmbh |
Die gastrointestinale Durchblutung fördernde Arzneimittel
|
CA2274250A1
(en)
|
1996-12-06 |
1998-06-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1.beta. converting enzyme
|
JPH10251295A
(ja)
|
1997-03-07 |
1998-09-22 |
Ono Pharmaceut Co Ltd |
テトラゾール誘導体
|
EP0994894A1
(en)
|
1997-08-11 |
2000-04-26 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6211174B1
(en)
|
1997-10-31 |
2001-04-03 |
Merck & Co., Inc. |
Naphtho-fused lactams promote release of growth hormone
|
FR2781483A1
(fr)
|
1998-07-21 |
2000-01-28 |
Hoechst Marion Roussel Inc |
Derives de thioazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicament et compositions pharmaceutiques les renfermant
|
DE19858253A1
(de)
|
1998-12-17 |
2000-06-21 |
Aventis Pharma Gmbh |
Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
|
JP2000256318A
(ja)
|
1999-03-02 |
2000-09-19 |
Toa Eiyo Ltd |
縮合複素環誘導体、その製造法およびそれを含有する医薬品
|
FR2803594B1
(fr)
|
2000-01-11 |
2002-07-19 |
Centre Nat Rech Scient |
Oligomeres de mimes contraints non peptidiques de dipeptides ou de tripeptides, et leurs utilisations
|
BR0107532A
(pt)
|
2000-04-03 |
2004-11-03 |
Bristol Myers Squibb Pharma Co |
Composto, uso do composto, método para o tratamento de disfunções neurológicas associadas com a produção de b-amilóide, método de inibição da atividade de y-secretase e composição farmacêutica
|
MXPA02009729A
(es)
|
2000-04-03 |
2003-03-27 |
Bristol Myers Squibb Pharma Co |
Lactamas ciclicas como inhibidores de la produccion de la proteina a-beta.
|
AU2001255408A1
(en)
|
2000-04-14 |
2001-10-30 |
Corvas International, Inc. |
Tetrahydro-azepinone derivatives as thrombin inhibitors
|
WO2001081330A2
(en)
|
2000-04-24 |
2001-11-01 |
Vertex Pharmaceuticals Incorporated |
Process and intermediates for making substituted aspartic acid acetals
|
GB0012671D0
(en)
|
2000-05-24 |
2000-07-19 |
Merck Sharp & Dohme |
Therapeutic agents
|
BR0106717A
(pt)
|
2000-06-01 |
2002-04-16 |
Bristol Myers Squibb Pharma Co |
Compostos, composição farmacêutica e usos dos compostos de lactama inovadora
|
AUPQ969800A0
(en)
|
2000-08-28 |
2000-09-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyrazolopyridine compound and pharmaceutical use thereof
|
US7179912B2
(en)
|
2000-09-01 |
2007-02-20 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
EP1411940B1
(en)
*
|
2001-07-18 |
2008-10-15 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
US7294457B2
(en)
|
2001-08-07 |
2007-11-13 |
Boehringer Ingelheim (Canada) Ltd. |
Direct binding assay for identifying inhibitors of HCV polymerase
|
WO2003031376A1
(en)
|
2001-10-12 |
2003-04-17 |
Aventis Pharmaceuticals Inc. |
Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
US6945933B2
(en)
|
2002-06-26 |
2005-09-20 |
Sdgi Holdings, Inc. |
Instruments and methods for minimally invasive tissue retraction and surgery
|
MXPA05000081A
(es)
|
2002-06-27 |
2005-04-11 |
Schering Ag |
Quinolinas sustituidas antagonistas del receptor ccr5.
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
WO2004055008A1
(en)
|
2002-12-13 |
2004-07-01 |
Smithkline Beecham Corporation |
Compounds, compositions and methods
|
EP1613368B1
(en)
|
2003-03-14 |
2011-11-30 |
Merck Sharp & Dohme Corp. |
Carboxamide spirohydantoin cgrp receptor antagonists
|
WO2004098589A1
(en)
|
2003-05-02 |
2004-11-18 |
Elan Pharmaceuticals, Inc. |
4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
|
JP2005035933A
(ja)
|
2003-07-15 |
2005-02-10 |
Takeda Chem Ind Ltd |
含窒素縮合複素環化合物の製造方法
|
SI2384753T1
(sl)
|
2003-08-29 |
2016-06-30 |
The Brigham And Women's Hospital, Inc. |
Hidantoinski derivati kot inhibitorji celične nekroze
|
MXPA06004006A
(es)
|
2003-10-10 |
2006-06-28 |
Vertex Pharma |
Inhibidores de serina proteasas, especialmente de ns3-ns4a proteasa del virus de la hepatitis c.
|
WO2005056577A2
(en)
|
2003-12-05 |
2005-06-23 |
The Regents Of The University Of California |
Peptide inhibitors of hiv
|
US7449599B2
(en)
*
|
2004-05-13 |
2008-11-11 |
Merck + Co Inc. |
Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
KR100966749B1
(ko)
*
|
2004-05-26 |
2010-06-30 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
신나미드 화합물
|
US20070010428A1
(en)
|
2004-09-03 |
2007-01-11 |
Mcmurray John S |
Inhibitors of signal transduction and activator of transcription 3
|
US7390798B2
(en)
|
2004-09-13 |
2008-06-24 |
Merck & Co., Inc. |
Carboxamide spirolactam CGRP receptor antagonists
|
CA2583536A1
(en)
|
2004-10-13 |
2006-04-27 |
Merck & Co., Inc. |
Cgrp receptor antagonists
|
EP1802372B1
(en)
|
2004-10-14 |
2011-05-04 |
Merck Sharp & Dohme Corp. |
Cgrp receptor antagonists
|
US20090099176A1
(en)
|
2004-12-02 |
2009-04-16 |
Thomas Martin Krulle |
Pyrrolopyridine-2-carboxylic acid amides
|
US7875627B2
(en)
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
US20060217362A1
(en)
|
2004-12-29 |
2006-09-28 |
Tung Jay S |
Novel compounds useful for bradykinin B1 receptor antagonism
|
WO2006079077A2
(en)
|
2005-01-20 |
2006-07-27 |
Acadia Pharmaceuticals Inc. |
Use of diltiazem or analogs thereof as modulators of ghrelin receptor
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
JP4109709B1
(ja)
|
2005-04-01 |
2008-07-02 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
統合失調症の治療のためのテトラヒドロ−ピリドアゼピン−8−オン及び関連化合物
|
US20080176830A1
(en)
|
2005-04-14 |
2008-07-24 |
Adams Nicholas D |
Compounds, Compositions, and Methods
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
RU2007147959A
(ru)
*
|
2005-06-08 |
2009-07-20 |
Новартис АГ (CH) |
Органические соединения
|
EA014244B1
(ru)
|
2005-09-23 |
2010-10-29 |
Коли Фармасьютикал Груп, Инк. |
СПОСОБ ПОЛУЧЕНИЯ 1-Н-ИМИДАЗО[4,5-c]ПИРИДИНОВ И ИХ АНАЛОГОВ
|
US7772415B2
(en)
*
|
2005-11-23 |
2010-08-10 |
Milliken & Company |
Radiation absorbing compositions, methods and articles incorporating such compositions
|
US20070117839A1
(en)
*
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
TWI370130B
(en)
*
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
JP2009518399A
(ja)
|
2005-12-05 |
2009-05-07 |
アフィニウム ファーマシューティカルズ, インク. |
Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
|
GB0605689D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
CN101454313A
(zh)
|
2006-03-29 |
2009-06-10 |
阿雷生物药品公司 |
P38抑制剂及其使用方法
|
AU2007252644A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Eisai R & D Management Co., Ltd. |
Heterocyclic type cinnamide derivative
|
JP2009543762A
(ja)
|
2006-06-09 |
2009-12-10 |
メルク エンド カムパニー インコーポレーテッド |
ナトリウムチャネル遮断薬としてのベンゾアゼピノン
|
CA2658506C
(en)
|
2006-07-20 |
2016-01-26 |
Affinium Pharmaceuticals, Inc. |
Acrylamide derivatives as fab 1 inhibitors
|
CN101516875A
(zh)
|
2006-07-21 |
2009-08-26 |
沃泰克斯药物股份有限公司 |
Cgrp受体拮抗剂
|
SA07280403B1
(ar)
*
|
2006-07-28 |
2010-12-01 |
إيساي أر أند دي منجمنت كو. ليمتد |
ملح رباعي لمركب سيناميد
|
JP5616063B2
(ja)
|
2006-10-04 |
2014-10-29 |
ヤンセン・アールアンドデイ・アイルランド |
Hcv阻害剤として有用なカルボキシアミド4−[(4−ピリジル)アミノ]ピリミジン
|
MX2009003821A
(es)
|
2006-10-10 |
2009-05-25 |
Amgen Inc |
Compuestos de n-aril pirazol para usarse contra la diabetes.
|
EP1939187A1
(en)
|
2006-12-20 |
2008-07-02 |
Sanofi-Aventis |
Substituted heteroaryl pyridopyrimidone derivatives
|
EP2518063B1
(en)
|
2006-12-21 |
2017-02-01 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
AU2008219723A1
(en)
|
2007-02-28 |
2008-09-04 |
Merck Sharp & Dohme Corp. |
Substituted benzodiazepinones, benzoxazepinones and benzothiazepinones as sodium channel blockers
|
WO2008135525A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted azetidines, manufacturing and use thereof as medicaments
|
EP2166854A4
(en)
|
2007-06-13 |
2012-05-16 |
Merck Sharp & Dohme |
TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND ASSOCIATED STATES
|
BRPI0814771A2
(pt)
|
2007-08-03 |
2015-03-03 |
Sanofi Aventis |
Sondas de imagem de caspase
|
WO2009085256A1
(en)
|
2007-12-27 |
2009-07-09 |
Panacos Pharmaceuticals, Inc. |
Anti-hiv compounds
|
EP2085399A1
(en)
|
2008-01-29 |
2009-08-05 |
Sanofi-Aventis |
substituted arylamide oxazepinopyrimidone derivatives
|
EP2090578A1
(en)
|
2008-01-29 |
2009-08-19 |
Sanofi-Aventis |
Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
|
JP4708443B2
(ja)
|
2008-01-31 |
2011-06-22 |
トヨタ自動車株式会社 |
作動制御マップおよび白線認識装置
|
AU2009215731A1
(en)
|
2008-02-19 |
2009-08-27 |
Merck Sharp & Dohme Corp. |
Imidazobenzazepine CGRP receptor antagonists
|
EP2262783A2
(en)
|
2008-02-21 |
2010-12-22 |
Sanofi-Aventis |
Covalently binding imaging probes
|
JP5699075B2
(ja)
|
2008-05-14 |
2015-04-08 |
アムジエン・インコーポレーテツド |
癌の治療のためのvegf(r)阻害剤および肝細胞増殖因子(c−met)阻害剤との組合せ
|
US7884074B2
(en)
|
2008-05-15 |
2011-02-08 |
Ikaria Development Subsidiary Two, LLC |
Compounds and methods for prevention and/or treatment of inflammation using the same
|
CA2731209A1
(en)
|
2008-07-28 |
2010-02-04 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
DE102008037790A1
(de)
|
2008-08-14 |
2010-02-18 |
Merck Patent Gmbh |
Bicyclische Triazolderivate
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
US8088890B2
(en)
|
2008-09-26 |
2012-01-03 |
Fibrex Medical Research & Development Gmbh |
Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
|
KR20110075016A
(ko)
|
2008-10-14 |
2011-07-05 |
닝 시 |
화합물 및 사용 방법
|
US8318928B2
(en)
*
|
2008-12-15 |
2012-11-27 |
Glenmark Pharmaceuticals, S.A. |
Fused imidazole carboxamides as TRPV3 modulators
|
JP2012512248A
(ja)
|
2008-12-17 |
2012-05-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Cgrp受容体アンタゴニストとしてのイミダゾリノン誘導体
|
WO2010083725A1
(zh)
|
2009-01-20 |
2010-07-29 |
山东轩竹医药科技有限公司 |
含有取代的含氮稠杂环的头孢菌素衍生物
|
US8624063B2
(en)
|
2009-06-30 |
2014-01-07 |
Wisconsin Alumni Research Foundation |
Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
|
WO2011035019A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Novel tricyclic protein kinase modulators
|
KR20120092141A
(ko)
|
2009-10-29 |
2012-08-20 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 비시클릭 피리딘 및 유사체
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
US20130137642A1
(en)
|
2010-04-23 |
2013-05-30 |
Demetrios Vavvas |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
CA2835596A1
(en)
|
2010-05-11 |
2011-11-17 |
8337187 Canada Inc. |
Benzo- or pyrido-imidazole derivative
|
KR20130122531A
(ko)
|
2010-05-24 |
2013-11-07 |
벤더르빌트 유니버시티 |
Mglur5 양성 알로스테릭 조절물로서 치환된 6메틸니코틴아미드
|
US9029501B2
(en)
|
2010-11-02 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Method for making macrocycles
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
TWI478908B
(zh)
|
2011-07-01 |
2015-04-01 |
Gilead Sciences Inc |
作為離子通道調節劑之稠合雜環化合物
|
KR20140063605A
(ko)
|
2011-07-19 |
2014-05-27 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
WO2013013826A1
(en)
|
2011-07-27 |
2013-01-31 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract
|
JO3148B1
(ar)
|
2011-07-27 |
2017-09-20 |
Lilly Co Eli |
مركب مثبط لإشارات مسار notch
|
US20140357570A1
(en)
|
2011-10-21 |
2014-12-04 |
Massachusetts Eye And Ear Infirmary |
Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
|
SG11201402409UA
(en)
|
2011-12-02 |
2014-10-30 |
Aurigene Discovery Tech Ltd |
Substituted pyridine derivatives as fabi inhibitors
|
US9062075B2
(en)
|
2011-12-02 |
2015-06-23 |
Aurigene Discovery Technologies Limited |
Tetrahydropyridine derivatives as FabI inhibitors
|
WO2013151739A1
(en)
|
2012-04-03 |
2013-10-10 |
3M Innovative Properties Company |
Crosslinkable composition comprising photobase generators
|
CN103958526B
(zh)
|
2012-06-20 |
2015-09-09 |
上海恒瑞医药有限公司 |
嘧啶二胺类衍生物、其制备方法及其在医药上的应用
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
BR112015000649A2
(pt)
|
2012-07-13 |
2017-06-27 |
Hoffmann La Roche |
compostos, composição farmacêutica, uso de um composto, método para tratar ou melhorar câncer e invenção
|
JP6266617B2
(ja)
|
2012-08-09 |
2018-01-24 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
置換ヘテロアゼピノン
|
CN103664904A
(zh)
|
2012-09-07 |
2014-03-26 |
李振 |
一种γ-分泌酶抑制剂及其用途
|
WO2014072930A2
(en)
|
2012-11-09 |
2014-05-15 |
Aurigene Discovery Technologies Limited |
Fused pyridine derivatives as antibacterial agents
|
TWI637951B
(zh)
|
2013-02-15 |
2018-10-11 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類
|
WO2014144547A2
(en)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California |
Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
|
FR3003860B1
(fr)
|
2013-03-29 |
2015-11-27 |
Oreal |
Composes derives d'iridoides proteges ou non, composition les comprenant, utilisation comme colorant des fibres keratiniques et dispositifs
|
US20160051629A1
(en)
|
2013-04-15 |
2016-02-25 |
Yeda Research And Development Co. Ltd. |
Inhibition of rip kinases for treating lysosomal storage diseases
|
WO2014210456A1
(en)
*
|
2013-06-28 |
2014-12-31 |
Emory University |
Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses
|
WO2015027137A1
(en)
|
2013-08-23 |
2015-02-26 |
University Of Tennessee Research Foundation |
Improved synthesis of capuramycin and its analogues
|
US20160326157A1
(en)
|
2014-01-06 |
2016-11-10 |
President And Fellows Of Harvard College |
Monobactams and methods of their synthesis and use
|
WO2015104677A1
(en)
|
2014-01-10 |
2015-07-16 |
Piramal Enterprises Limited |
Heterocyclic compounds as ezh2 inhibitors
|
US10065951B2
(en)
|
2014-05-30 |
2018-09-04 |
Icahn School Of Medicine At Mount Sinai |
Small molecule transcription modulators of bromodomains
|
US9616047B2
(en)
|
2014-06-30 |
2017-04-11 |
Regents Of University Of Minnesota |
Inhibitors of beta-catenin in treatment of colorectal cancer
|
US20170226514A1
(en)
|
2014-08-13 |
2017-08-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Prevention of tumour metastasis by inhibition of necroptosis
|
US20170266199A1
(en)
|
2014-08-21 |
2017-09-21 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides as rip1 kinase inhibitors as medicaments
|
JP6820254B2
(ja)
|
2014-10-10 |
2021-01-27 |
ジェネンテック, インコーポレイテッド |
治療用化合物およびその使用
|
EP3017825A1
(en)
|
2014-11-06 |
2016-05-11 |
Ludwig-Maximilians-Universität München |
An inhibitor of the RIPK1-dependent necrosis pathway and a pharmaceutical composition comprising the same
|
JP6772141B2
(ja)
|
2014-12-24 |
2020-10-21 |
ナショナル・インスティチュート・オブ・バイオロジカル・サイエンシズ,ベイジン |
ネクローシス阻害薬
|
AU2015371824B2
(en)
*
|
2014-12-24 |
2019-09-19 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|
JP6667551B2
(ja)
|
2015-01-13 |
2020-03-18 |
ノバルティス アーゲー |
アンジオテンシンii2型拮抗薬としてのピロリジン誘導体
|
KR20170117472A
(ko)
|
2015-02-13 |
2017-10-23 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
(S)-5-벤질-N-(5-메틸-4-옥소-2,3,4,5-테트라히드로벤조[b][1,4]옥사제핀-3-일)-4H-1,2,4-트리아졸-3-카르복사미드의 결정질 형태
|
TWI609687B
(zh)
|
2015-04-14 |
2018-01-01 |
美國禮來大藥廠 |
平滑肌肉瘤之標靶性治療
|
MY192762A
(en)
|
2015-07-02 |
2022-09-07 |
Hoffmann La Roche |
Bicyclic lactams and methods of use thereof
|
KR101858346B1
(ko)
|
2015-07-07 |
2018-05-16 |
가톨릭대학교 산학협력단 |
Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
|
JP6754772B2
(ja)
|
2015-10-23 |
2020-09-16 |
武田薬品工業株式会社 |
複素環化合物
|
US10961258B2
(en)
|
2015-12-21 |
2021-03-30 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides as kinase inhibitors
|
CN110914275A
(zh)
*
|
2017-05-17 |
2020-03-24 |
戴纳立制药公司 |
化合物、组合物及方法
|